NZ599006A - Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof - Google Patents

Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Info

Publication number
NZ599006A
NZ599006A NZ599006A NZ59900610A NZ599006A NZ 599006 A NZ599006 A NZ 599006A NZ 599006 A NZ599006 A NZ 599006A NZ 59900610 A NZ59900610 A NZ 59900610A NZ 599006 A NZ599006 A NZ 599006A
Authority
NZ
New Zealand
Prior art keywords
methyl
formula
fluoro
indazol
dihydropyridine
Prior art date
Application number
NZ599006A
Other languages
English (en)
Inventor
Alexandros Vakalopoulos
Maria Kissel
Donald Bierer
Martin Michels
Katja Zimmermann
Nicole Teusch
Karen Engel
Markus Follmann
Mario Lobell
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of NZ599006A publication Critical patent/NZ599006A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NZ599006A 2009-10-06 2010-10-01 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof NZ599006A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172304 2009-10-06
PCT/EP2010/064648 WO2011042368A1 (en) 2009-10-06 2010-10-01 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Publications (1)

Publication Number Publication Date
NZ599006A true NZ599006A (en) 2013-11-29

Family

ID=43357944

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ599006A NZ599006A (en) 2009-10-06 2010-10-01 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Country Status (27)

Country Link
US (1) US9422263B2 (OSRAM)
EP (1) EP2485726B1 (OSRAM)
JP (1) JP5753175B2 (OSRAM)
KR (1) KR20120091005A (OSRAM)
CN (1) CN102573838B (OSRAM)
AR (1) AR078486A1 (OSRAM)
AU (1) AU2010305550A1 (OSRAM)
BR (1) BR112012006842A2 (OSRAM)
CA (1) CA2773676C (OSRAM)
CL (1) CL2012000753A1 (OSRAM)
CR (1) CR20120150A (OSRAM)
CU (1) CU20120051A7 (OSRAM)
DO (1) DOP2012000085A (OSRAM)
EC (1) ECSP12011748A (OSRAM)
ES (1) ES2458117T3 (OSRAM)
IL (1) IL218415A0 (OSRAM)
IN (1) IN2012DN02675A (OSRAM)
MX (1) MX2012003603A (OSRAM)
NZ (1) NZ599006A (OSRAM)
PE (1) PE20121392A1 (OSRAM)
PH (1) PH12012500640A1 (OSRAM)
RU (1) RU2012111695A (OSRAM)
SG (1) SG178990A1 (OSRAM)
TW (1) TW201124396A (OSRAM)
UY (1) UY32922A (OSRAM)
WO (1) WO2011042368A1 (OSRAM)
ZA (1) ZA201201524B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0650179Y2 (ja) 1989-06-01 1994-12-21 株式会社プラコー ブロー成形機用のダイヘッド
JPH0756186Y2 (ja) 1989-07-24 1995-12-25 株式会社日本製鋼所 パリソンの押出成形装置
JP2781376B2 (ja) 1996-06-17 1998-07-30 エクセル株式会社 中空成形品
DE102009056886A1 (de) * 2009-12-03 2011-06-09 Bayer Schering Pharma Aktiengesellschaft cMet-Inhibitoren zur Behandlung der Endometriose
SI3924340T1 (sl) 2019-02-11 2025-04-30 Merck Patent Gmbh Derivati indazolil-izoksazola za zdravljenje bolezni, kot je na primer rak

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635977A (en) 1969-11-03 1972-01-18 American Cyanamid Co Certain 6-trifluoromethylcytosines and thiocytosines their synthesis and their use in the synthesis of uracisls and thiouracil
EP0379917B1 (de) 1989-01-26 1995-08-09 Bayer Ag Optisch aktive (Meth)Acrylsäure-Derivate, ihre Herstellung, ihre Polymerisation zu optisch aktiven Polymeren und deren Verwendung
DE19546136A1 (de) 1995-12-11 1997-06-12 Bayer Ag Chirale stationäre Phasen für die chromatographische Trennung von optischen Isomeren
KR20050004214A (ko) 2002-05-31 2005-01-12 에자이 가부시키가이샤 피라졸 화합물 및 이것을 포함하여 이루어지는 의약 조성물
JP2007526324A (ja) 2004-03-02 2007-09-13 スミスクライン・ビーチャム・コーポレイション Akt活性のある阻害剤
WO2005084672A1 (de) 2004-03-03 2005-09-15 Boehringer Ingelheim International Gmbh Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
JP2008523108A (ja) 2004-12-13 2008-07-03 アイアールエム・リミテッド・ライアビリティ・カンパニー ステロイドホルモン核内受容体およびカルシウムチャネル活性のモジュレーターとしての化合物および組成物
CA2603676A1 (en) 2005-01-07 2006-07-13 Roskamp Research Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
EP1855664A4 (en) * 2005-01-19 2009-12-23 Merck & Co Inc INHIBITORS OF MITOTIC KINESINE
EP2121608B1 (en) 2006-12-14 2012-11-14 Bayer Intellectual Property GmbH Dihydropyridine derivatives useful as protein kinase inhibitors

Also Published As

Publication number Publication date
HK1172835A1 (en) 2013-05-03
US20120264785A1 (en) 2012-10-18
SG178990A1 (en) 2012-04-27
KR20120091005A (ko) 2012-08-17
CU20120051A7 (es) 2012-06-29
MX2012003603A (es) 2012-04-20
PH12012500640A1 (en) 2012-11-12
JP2013506699A (ja) 2013-02-28
BR112012006842A2 (pt) 2016-06-07
UY32922A (es) 2011-04-29
TW201124396A (en) 2011-07-16
EP2485726B1 (en) 2014-03-12
CR20120150A (es) 2012-08-03
CA2773676C (en) 2017-07-04
IN2012DN02675A (OSRAM) 2015-09-04
IL218415A0 (en) 2012-04-30
JP5753175B2 (ja) 2015-07-22
EP2485726A1 (en) 2012-08-15
ES2458117T3 (es) 2014-04-30
AU2010305550A1 (en) 2012-03-29
CA2773676A1 (en) 2011-04-14
CN102573838B (zh) 2014-09-24
WO2011042368A1 (en) 2011-04-14
CN102573838A (zh) 2012-07-11
ECSP12011748A (es) 2012-05-30
US9422263B2 (en) 2016-08-23
DOP2012000085A (es) 2012-07-15
CL2012000753A1 (es) 2012-09-14
AR078486A1 (es) 2011-11-09
RU2012111695A (ru) 2013-10-10
PE20121392A1 (es) 2012-10-14
ZA201201524B (en) 2013-05-29

Similar Documents

Publication Publication Date Title
NZ599006A (en) Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof
SI2091948T1 (sl) Novi inhibitorji glutaminil ciklaze
Zhang et al. Photocatalyzed Minisci-type reactions for late-stage functionalization of pharmaceutically relevant compounds
HRP20202050T1 (hr) Derivati imidazolina, postupci njihove pripreme i njihova medicinska primjena
EA201170098A1 (ru) Замещенные производные алкилпиримидин-4-она
PT2428519E (pt) Processo para preparação de 17-o-vinil-triflatos como intermediários
NZ599444A (en) Novel heterocyclic acrylamides and their use as pharmaceuticals
EP3456721A3 (en) Method of producing compounds having hiv integrase inhivitory activity
MX2007004215A (es) Proceso para la sintesis de 4-(3-metansulfonilfenil)-1-n- propilpiperidina.
ZA200710145B (en) Method for the production of 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl-benzofuran-2-carboxamide
WO1999059971A1 (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses
JP2012507525A5 (OSRAM)
PE20100155A1 (es) Derivados de urea heterociclicos y metodos de uso de los mismos-332
MX362102B (es) Método para producir 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3-il]pir idina-2-carbonitrilo e intermediario del mismo.
TW200540158A (en) Novel hydroxy-6-heteroarylphenanthridines
NZ599747A (en) Process for the preparation of benzoimidazol-2-yl pyrimidine derivatives
EA200700360A1 (ru) Новые производные амида гетероциклической карбоновой кислоты
EA201001252A1 (ru) Способ получения производных 3,6-дигидро-1,3,5-триазина
NO20084691L (no) Piperidinerivater som er nyttige for bahandling av osteoarttitt og osteoartrose
AR118649A1 (es) Opciones sintéticas hacia la fabricación de (6r,10s)-10-{4-[5-cloro-2-(4-cloro-1h-1,2,3-triazol-1-il)fenil]-6-oxo-1(6h)-pirimidinil}-1-(difluorometil)-6-metil-1,4,7,8,9,10-hexahidro-11,15-(meteno)pirazol[4,3-b][1,7]diazaciclotetradecin-5(6h)-ona
DK2234974T3 (da) Fremgangsmåde til fremstilling af (S)-1-alkyl-2',6'-pipecoloxylidid-forbindelse
EP1948646A2 (en) Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
WO2007135693A3 (en) Intermediates useful for the preparation of antihistaminic piperidine derivative
BRPI0514077A (pt) derivados de benzilóxi como inibidores de maob
SI2260034T1 (sl) Postopek priprave estrov tetrahidro h beta karbolin karboksilne kisline

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: BAYER INTELLECTUAL PROPERTY GMBH, DE

Effective date: 20130815

PSEA Patent sealed
LAPS Patent lapsed